Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864719/
https://www.ncbi.nlm.nih.gov/pubmed/35228872
http://dx.doi.org/10.1002/cti2.1378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864719/
https://www.ncbi.nlm.nih.gov/pubmed/35228872
http://dx.doi.org/10.1002/cti2.1378

Ejemplares similares